Using knowledge, attitudes and practice (KAP) surveys on lymphatic filariasis to prepare a health promotion campaign for mass drug administration in Alor District, Indonesia.
We report the results of two surveys of people's knowledge, attitudes and practices (KAP) regarding lymphatic filariasis (LF) in Alor District, eastern Indonesia. The results of the surveys were used to prepare and evaluate the social mobilization component of a pilot mass drug administration (MDA) in five villages. In the study area, the filarial parasites Brugia timori and Wuchereria bancrofti are highly endemic. Frequent and severe adverse reactions after MDA may occur especially in areas endemic for B. timori and therefore, a special communication strategy was designed to inform and to educate communities about LF and its control. The first KAP survey was conducted as a baseline pre-MDA with diethylcarbamazine and albendazole and the second as a post-intervention evaluation in order to obtain information on the impact of the communication campaign. Before the information campaign and the subsequent MDA, 54% of the study population had heard of one of the three main terms for LF, whereas after health education and MDA, 89% had heard of at least one of the three terms. Similarly, pre-MDA, 21% reported having had previously taken the treatment for filariasis, while post-MDA, 88% reported having taken the treatment during the pilot treatment period. The historical fears and traumatic experiences associated with past LF treatment campaigns in Indonesia were averted since both the communication campaign and the MDA were designed appropriately for and together with the community. As a result, compliance was sufficient in the first round to successfully begin the elimination process.
Krentel
Alison
A
Deutsche Gesellschaft für Technische Zusammenarbeit (GTZ) SISKES Project, Kupang, Indonesia. alison.krentel@lshtm.ac.uk
Fischer
Peter
P
Manoempil
Paul
P
Supali
Taniawati
T
Servais
Gérard
G
Rückert
Paul
P
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D000369:Aged, 80 and over; D015766:Albendazole / Q000009:adverse effects / Q000627:therapeutic use; D000871:Anthelmintics / Q000009:adverse effects / Q000627:therapeutic use; D003142:Communication; D004049:Diethylcarbamazine / Q000009:adverse effects / Q000627:therapeutic use; D004605:Elephantiasis, Filarial / Q000453:epidemiology / Q000517:prevention & control / Q000523:psychology*; D019353:Endemic Diseases / Q000517:prevention & control; D005260:Female; D005369:Filaricides / Q000009:adverse effects / Q000627:therapeutic use; D006266:Health Education / Q000379:methods; D007722:Health Knowledge, Attitudes, Practice; D006293:Health Promotion / Q000379:methods*; D006801:Humans; D007214:Indonesia / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D011159:Population Surveillance / Q000379:methods; D012423:Rural Health; D012959:Socioeconomic Factors; D009626:Terminology as Topic
D000871:Anthelmintics; D005369:Filaricides; D015766:Albendazole; D004049:Diethylcarbamazine